PubMed Health⌕ Search

PubMed · 1754615

Electromagnetic radiofrequency interference with Doppler equipment.

Abstract

Doppler ultrasound equipments incorporate radiofrequency (RF) receivers operating at the microvolt level and are liable to interference from radiated fields and mains disturbances. The most significant interference routes are: radiation from radio broadcast, paging, communication and diathermy picked up on the transducer and patient acting as an aerial; and mains disturbances from diathermy, x-ray sets, motors and thyristor controls, etc, reaching the equipment interior. Direct mains interference can be reduced by proper design incorporating a mains filter, a low RF leakage enclosure, a ground plane, careful layout and further screening of the receiver circuits. Pick-up via the transducer occurs even if the signal leads are completely screened because an RF potential can exist between transducer and equipment enclosure due to the considerable impedance at RF of any wire or cable, typically 70 omega at 5 MHz for 2 m. This potential, reduced by about 50-60 dB, appears at the receiver input because of imperfect common mode rejection of the coupling cable. As a result, induced voltages above 100-300 microV may cause problems. It is shown that such levels can easily result from the interfering field strengths of 1 mV m-1 or more that may be experienced in a hospital environment. On the other hand, field strengths of 300 microV m-1, as generally allowed by regulatory standards at 3 m from interfering sources, should not cause much effect. Other interference can arise from modulation of a strong RF signal by mains frequency power components in the Doppler equipment and from associated computer circuits. These require careful layout to reduce electric and magnetic coupling, decoupling and filtering of power supplies and components, screening of RF circuits and particular attention to the reduction of power and computer signal currents flowing in RF signal earth paths. Finally, some initial simple acceptance tests for interference susceptibility are proposed, based on the application of 300 microV of RF signal between transducer body and equipment enclosure and 10 mV to the mains supply.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

D H Follett. 1991. Electromagnetic radiofrequency interference with Doppler equipment.. https://doi.org/10.1088/0031-9155%2F36%2F11%2F004

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

An impact assessment of the European medical device regulations implementation - the current status quo.

BACKGROUND: This research aims to assess the current impact of the medical and in-vitro diagnostic devices regulations (MDR/IVDR) on the device industry in the EU, under the lens of postimplementation and the amending regulation, and in advance of the final transition to the IVDR/MDR in the future. RESEARCH DESIGN AND METHODS: A quantitative survey was administered to a diverse cohort of medical device enterprises, ranging from micro to large organizations. RESULTS: The survey indicates that the MDR/IVDR has harmed innovation, leading many manufacturers to seek initial device approval and launch elsewhere before in Europe. There is evidence that some manufacturers have rationalized their existing product portfolios and removed devices from the market as they stated they would in previous industry surveys. The MDR/IVDR has been shown to negatively impact manufacturers, with increased costs related to notified body (NB) fees, maintaining and updating documentation, recertification fees, and hiring additional staff. CONCLUSION: This study provides a current status of the effects of MDR/IVDR on manufacturers and finds that despite amending regulations and other interventions taken by the EU to mitigate regulatory burden, ensure product availability, and address stakeholder concerns, the EU is no longer the market of choice for new products.

Equipment and Supplies↗

In vitro pyrogen test--A new test method for solid medical devices.

Medical devices manufactured for implantation into humans must be free of any contamination with viable bacteria. However, remnants of dead bacteria and bacterial components alone may induce an inflammatory immune response. Pyrogen tests for such inflammatory contaminations are generally performed either by determining the content of lipopolysaccharide in rinsing solutions of batch samples by limulus amoebocyte lysate assay, by injecting the rinsing solutions into rabbits or by implanting batch samples into rabbits and measuring change of body temperature. In this study, we show that the in vitro pyrogen test (IPT), which measures the release of the inflammatory cytokine IL-1beta in fresh or cryopreserved human whole blood, can be used to assess the pyrogenic contamination of implantable medical devices. This test was used to check neurosurgical implants, namely aneurysm clips, as a proof of principle. Owing to the direct contact of the test material with the blood cells, this test does not require rinsing procedures, which have variable efficacy. The use of human blood ensures the detection of all substances that are pyrogenic for humans and reflects their relative potency. The safety of the products as delivered could be confirmed. The effects of sterilization and depyrogenization procedures on intentional pyrogenic contaminations of samples could be followed. This new application of the already internationally validated method promises to replace further rabbit pyrogen tests. It generates extremely sensitive results with an extended range of detectable pyrogenic contaminants.

Equipment and Supplies↗